 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/15/2020 |
$2.58 |
$2.70 |
$2.52 |
$2.64 |
1.21M | | 01/16/2020 |
$2.67 |
$2.77 |
$2.54 |
$2.54 |
900.30K | | 01/17/2020 |
$2.57 |
$2.60 |
$2.52 |
$2.54 |
1.36M | | 01/21/2020 |
$2.55 |
$2.92 |
$2.51 |
$2.78 |
2.92M | | 01/22/2020 |
$2.83 |
$2.88 |
$2.75 |
$2.86 |
1.20M |
|
|
| Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101 an AAV-based gene therapy for Sanfilippo syndrome type B. Co. is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases. |
|
|
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on January 15, 2020, ABEO opened at $2.58, traded as high as $2.70 and as low as $2.52, and closed at $2.64. Trading volume was a total of 1.21M shares. On January 16, 2020, ABEO opened at $2.67, traded as high as $2.77 and as low as $2.54, and closed at $2.54. Trading volume was a total of 900.30K shares. On January 17, 2020, ABEO opened at $2.57, traded as high as $2.60 and as low as $2.52, and closed at $2.54. Trading volume was a total of 1.36M shares. On January 21, 2020, ABEO opened at $2.55, traded as high as $2.92 and as low as $2.51, and closed at $2.78. Trading volume was a total of 2.92M shares. On January 22, 2020, ABEO opened at $2.83, traded as high as $2.88 and as low as $2.75, and closed at $2.86. Trading volume was a total of 1.20M shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/25/2010 |
|
| End date: |
01/22/2020 |
|
| Start price/share: |
$2.80 |
|
| End price/share: |
$2.86 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
2.14% |
|
| Average Annual Total Return: |
0.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$10,211.94 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/15/2020 | $2.64 | | 01/16/2020 | $2.54 | | 01/17/2020 | $2.54 | | 01/21/2020 | $2.78 | | 01/22/2020 | $2.86 |
|
|
